Hydrolyzed casein decreases postprandial glucose concentrations in T2DM patients irrespective of leucine content

Journal of Dietary Supplements

Volumn 8, Issue 3, 2011, Pages 280-292

  Geerts, Bart F ^b   Van Dongen, Marloes G J ^a   Flameling, Baukje ^a   Moerland, Matthijs M ^a   Kam, Marieke L De ^a   Cohen, Adam F ^a   Romijn, Johannes A ^b   Gerhardt, Cindy C ^c   Kloek, Joris ^c   Burggraaf, Jacobus ^a  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DSM RESOLVE   (Netherlands)

Author keywords

Glucagon; Glucose; Insulin; Meal replacement; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; CASEIN; GLUCAGON; INSULIN; LEUCINE; PROTEIN HYDROLYSATE;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL;

AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CASEINS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLUCAGON; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LEUCINE; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PROTEIN HYDROLYSATES;

EID: 80555136554     PISSN: 19390211     EISSN: 1939022X     Source Type: Journal    
DOI: 10.3109/19390211.2011.593617     Document Type: Article

References (34)

1. AhmedM, Nuttall FQ, Gannon MC, Lamusga RF. Plasma glucagon and alpha-amino acid nitrogen response to various diets in normal humans. Am J Clin Nutr. 1980;33(9):1917-1924.
2. Althuis MD, Jordan NE, Ludington EA, Wittes JT. Glucose and insulin responses to dietary chromium supplements: A meta-analysis. Am J Clin Nutr. 2002;76(1):148-155.
3. Avignon A, Radauceanu A,Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 1997;20(12):1822-1826.
4. Calbet JA, Holst JJ. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr. 2004;43(3):127-139.
5. Calbet JA, MacLean DA. Plasma glucagon and insulin responses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans. J Nutr. 2002;132(8):2174-2182.
6. Carroll MF, Gutierrez A, Castro M, Tsewang D, Schade DS. Targeting postprandial hyperglycemia: A comparative study of insulinotropic agents in type 2 diabetes. J Clin Endocrinol Metab. 2003;88(11):5248-5254.
7. Claessens M, Calame W, SiemensmaAD, vanBaak MA,SarisWH.The effect of different protein hydrolysate/carbohydrate mixtures on postprandial glucagon and insulin responses in healthy subjects. Eur J Clin Nutr. 2009;63(1):48-56.
8. CochraneWA, Payne WW, Simpkiss MJ,Woolf LI. Familial hypoglycemia precipitated by amino acids. J Clin Invest. 1956;35(4):411-422.
9. Day JL, Johansen K, Ganda OP, Soeldner JS, Gleason RE,Midgley W. Factors governing insulin and glucagon responses during normal meals. Clin Endocrinol (Oxf). 1978;9(5):443-454.
10. Frid AH, Nilsson M, Holst JJ, Bjorck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr. 2005;82(1):69-75.
11. Gannon MC, Nuttall FQ, Neil BJ, Westphal SA. The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects.Metabolism. 1988;37(11):1081-1088.
12. Gannon MC, Nuttall FQ, Saeed A, Jordan K, Hoover H. An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. Am J Clin Nutr. 2003;78(4):734-741.
13. Guerrero-Romero F, Rodriguez-Moran M. Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants. Arch Med Res. 2005;36(3):250-257.
14. Kabadi UM. Dose-kinetics of pancreatic alpha- and beta-cell responses to a protein meal in normal subjects. Metabolism. 1991;40(3):236-240.
15. Kloek J, Pasupuleti VK, van Loon LJC. Proteins, protein hydrolysates, and bioactive peptides in the management of type 2 diabetes. In: Pasupuleti VK, Anderson JW (Eds.), Nutraceuticals, glycemic health and type 2 diabetes, pp. 503-528. Iowa: IFT Press Series,Wiley-Blackwell, 2008.
16. KnowlerWC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM,Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
17. Manders RJ, Koopman R, Sluijsmans WE, van den BR, Verbeek K, Saris WH, Wagenmakers AJ, van Loon LJ. Co-ingestion of a protein hydrolysate with or without additional leucine effectively reduces postprandial blood glucose excursions in type 2 diabetic men. J Nutr. 2006a;136(5):1294-1299.
18. Manders RJ, Praet SF, Meex RC, Koopman R, de Roos AL, Wagenmakers AJ, Saris WH, van Loon LJ. Protein hydrolysate/leucine co-ingestion reduces the prevalence of hyperglycemia in type 2 diabetic patients. Diabetes Care 2006b;29(12):2721-2722.
19. Manders RJ, Praet SF, Vikstrom MH, SarisWH, van Loon LJ. Protein hydrolysate co-ingestion does not modulate 24 h glycemic control in long-standing type 2 diabetes patients. Eur J Clin Nutr. 2009;63(1):121-126.
20. Manders RJ, Wagenmakers AJ, Koopman R, Zorenc AH, Menheere PP, Schaper NC, Saris WH, van Loon LJ. Co-ingestion of a protein hydrolysate and amino acid mixture with carbohydrate improves plasma glucose disposal in patients with type 2 diabetes. Am J Clin Nutr. 2005;82(1):76-83.
21. Matthews DR, Boland O. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state. Metabolism. 1997;46 (12, Suppl 1):5-9.
22. Newsholme P, Brennan L, Rubi B, Maechler P. New insights into amino acid metabolism, betacell function and diabetes. Clin Sci (Lond). 2005;108(3):185-194.
23. Nuttall FQ, Mooradian AD, Gannon MC, Billington C, Krezowski P. Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care 1984;7(5):465-470.
24. Pallotta JA, Kennedy PJ. Response of plasma insulin and growth hormone to carbohydrate and protein feeding. Metabolism. 1968;17(10):901-908.
25. Pipeleers DG, Schuit FC, Van Schravendijk CF, Van de WM. Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology. 1985;117(3):817-823.
26. Proks P, Reimann F, Green N, Gribble F, Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes. 2002;51 (Suppl, 3):S368-S376.
27. RabinowitzD,Merimee TJ,Maffezzoli R, Burgess JA. Patterns of hormonal release after glucose, protein, and glucose plus protein. Lancet. 1966;2(7461):454-456.
28. Roumen C, Corpeleijn E, Feskens EJ, Mensink M, Saris WH, Blaak EE. Impact of 3-year lifestyle intervention on postprandial glucose metabolism: The SLIM study. Diabet Med. 2008;25(5):597-605.
29. Sener A, Malaisse WJ. L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature. 1980;288(5787):187-189.
30. van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH, Keizer HA. Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 2003;26(3):625-630.
31. van Loon LJ, Kruijshoop M, Verhagen H, Saris WH, Wagenmakers AJ. Ingestion of protein hydrolysate and amino acid-carbohydrate mixtures increases postexercise plasma insulin responses in men. J Nutr. 2000a;130(10):2508-2513.
32. van Loon LJ, Saris WH, Verhagen H, Wagenmakers AJ. Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. Am J Clin Nutr. 2000b;72(1):96-105.
33. van Loon LJC. Amino acids as pharmaco-nutrients for the treatment of type 2 diabetes. Immun Endoc Metab Agents Med Chem. 2006;6:39-48.
34. Wakeling IN, MacFie HJH. Designing consumer trials balanced for first and higher orders of carry-over effect when only a subset of k samples from t may be tested. Food Qual Prefer. 1995;6:299-308.